These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4479624)

  • 41. The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.
    Chou FF; Wang PW; Sheen-Chen SM
    J Endocrinol Invest; 1994 Jan; 17(1):41-4. PubMed ID: 7911812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the clinical importance of thyroid microsomal and thyroglobulin antibody determination.
    Scherbaum WA
    Acta Endocrinol Suppl (Copenh); 1987; 281():325-9. PubMed ID: 3475912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HL-A in Graves' disease and in diabetes mellitus insulin-dependent.
    Seignalet J; Mirouze J; Jaffiol C; Selam JL; Lapinski H
    Tissue Antigens; 1975 Oct; 6(4):272-4. PubMed ID: 1242826
    [No Abstract]   [Full Text] [Related]  

  • 44. HL-A antibodies and cold lymphocytotoxins.
    Mayer S; Falkenrodt A; Tongio MM
    Tissue Antigens; 1974; 4(4):387-94. PubMed ID: 4137710
    [No Abstract]   [Full Text] [Related]  

  • 45. A sensitive enzyme immunoassay for anti-thyroglobulin antibody using Fab'-horseradish peroxidase conjugate. Evaluation of in vitro anti-thyroglobulin antibody synthesis by lymphocytes from patients with autoimmune thyroid disease.
    Hoshijima Y; Kosaka M; Okagawa K; Goto T; Saito S
    J Immunol Methods; 1987 Jan; 96(1):121-6. PubMed ID: 3543133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of some of the HL-A system lymphocyte antigens in Mexicans. II. Studies in atopics and in lepers.
    Escorbar-Gutiérrez A; Gorodezky C; Salazar-Mallén M
    Vox Sang; 1973; 25(2):151-5. PubMed ID: 4737546
    [No Abstract]   [Full Text] [Related]  

  • 47. [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].
    Bertrams J; Kuwert E; Reis HE; Selmair H; Wiese W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):372-7. PubMed ID: 4154614
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin autoantibodies in Graves' disease--before and after carbimazole therapy.
    Armitage M; Franklyn J; Scott-Morgan L; Parr J; Borsey DQ; Sheppard M; Wilkin TJ
    Diabetes Res Clin Pract; 1990 Mar; 8(3):169-76. PubMed ID: 2340791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
    Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
    Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HL-A phenotype and haplotype frequencies in a German population.
    Gleichmann H
    Tissue Antigens; 1974; 4(2):157-65. PubMed ID: 4837426
    [No Abstract]   [Full Text] [Related]  

  • 53. Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis.
    Field EJ; Caspary EA; Hall R; Clark F
    Lancet; 1970 May; 1(7657):1144-7. PubMed ID: 4192099
    [No Abstract]   [Full Text] [Related]  

  • 54. HL-A antigens and some immunological parameters in psoriasis.
    Seignalet J; Clot J; Guilhou JJ; Duntze F; Meynadier J; Robinet-Levy M
    Tissue Antigens; 1974; 4(1):59-68. PubMed ID: 4209911
    [No Abstract]   [Full Text] [Related]  

  • 55. IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen.
    McLachlan SM; Feldt-Rasmussen U; Young ET; Middleton SL; Dlichert-Toft M; Siersboek-Nielsen K; Date J; Carr D; Clark F; Rees Smith B
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):335-46. PubMed ID: 3652478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgA class and subclass thyroid auto-antibodies in Graves' disease and Hashimoto's thyroiditis.
    Weetman AP
    Int Arch Allergy Appl Immunol; 1987; 83(4):432-5. PubMed ID: 3610353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
    Ikekubo K
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
    Fisfalen ME; DeGroot LJ; Quintans J; Franklin WA; Soltani K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.